MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DSO Ratio 2011-2026 | OXFD
Annual DSO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 90.8 | 83.4 | 60.1 | 56.2 | 41 | 50.3 | 44.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 | 41 | 60.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
63.8 | $ 135.53 | 0.11 % | $ 41.2 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
94.7 | $ 8.53 | -23.77 % | $ 11.3 M | USA |
 |
Castle Biosciences
CSTL
|
50.2 | $ 21.08 | -4.66 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
87 | $ 18.14 | -0.55 % | $ 558 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 129.69 | -2.65 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.82 | 0.53 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
63.4 | $ 136.07 | -0.53 % | $ 10.7 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.7 | -5.56 % | $ 7.52 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 162.96 | 2.68 % | $ 25.9 B | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 99.3 | -0.32 % | $ 6.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 180.58 | 1.47 % | $ 24.3 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
65 | $ 180.71 | -0.35 % | $ 8.96 B | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 10.52 | 3.24 % | $ 1.35 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 19.53 | -0.66 % | $ 437 M | USA |
 |
Natera
NTRA
|
81.5 | $ 223.37 | 4.41 % | $ 22 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 447.11 | -0.23 % | $ 12.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
52.3 | $ 3.97 | -5.92 % | $ 368 M | USA |
 |
Personalis
PSNL
|
63.8 | $ 11.4 | 3.83 % | $ 1.02 B | USA |
 |
Senseonics Holdings
SENS
|
1.04 | $ 6.79 | 1.04 % | $ 283 M | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 66.87 | -3.13 % | $ 4 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.39 | -1.74 % | $ 5.49 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 260.06 | -0.75 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 492.51 | 1.09 % | $ 186 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.7 | -0.16 % | $ 251 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
66.6 | $ 8.97 | -3.55 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 194.9 | -0.72 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |